Medwise.ai Raises £1M to Build the AI Clinical Knowledge Engine for Doctors

Medwise.ai, a UK health technology company, has raised £1 million from Finance Yorkshire Seedcorn, British Business Bank Investments (BBI), Calm/Storm Ventures, and Deeptech Labs to develop its AI-powered clinical knowledge platform for medical professionals. The company operates a platform that enables doctors and clinicians to pose clinical questions in natural language and receive answers drawn from a curated, trustworthy set of medical literature, clinical guidelines, and evidence sources — giving clinicians rapid access to evidence-based guidance without needing to manually search multiple databases or guidelines resources.

The challenge Medwise addresses is a familiar one for anyone who has worked in clinical medicine. A busy GP or hospital doctor making dozens of clinical decisions each day frequently encounters questions that require checking a guideline, looking up a drug interaction, or finding the evidence for an unfamiliar clinical presentation. Current tools for answering these questions — searching PubMed, consulting BNF, navigating NICE guidelines — are slow, fragmented, and require the user to interpret technical literature rather than getting a direct answer. Clinicians frequently either spend significant time on lookups that interrupt the flow of a consultation, or make decisions from memory that may not reflect the most current guidelines.

Medwise.ai's platform applies large language models trained on medical literature to provide direct, cited answers to clinical questions — synthesising the relevant evidence and guidelines into a response that gives the clinician actionable guidance rather than a list of documents to read. Crucially, the system is designed to cite its sources and to be transparent about uncertainty, giving clinicians the information they need to assess the quality of the evidence behind any recommendation. This is critical for clinical use: the problem with generic AI systems in clinical contexts is not just hallucination of facts but the absence of the source citation that allows a clinician to evaluate and verify the recommendation before acting on it.

Calm/Storm Ventures and Deeptech Labs, both active in UK health AI, bring networks across the NHS and health innovation ecosystem. The funding will be used to develop the platform's clinical knowledge base, ensure accuracy and safety of AI-generated responses, and build partnerships with NHS trusts and primary care networks for clinical validation and adoption.

Sources

• Medwise.ai — company website